Cargando…
The Continuing Emergence of Candida blankii as a Pathogenic Fungus: A New Case of Fungemia in a Patient Infected with SARS-CoV-2
Candida blankii is a recently recognized human pathogen, with most cases of the infection being reported in the immunocompromised. We here describe the case of a critically ill elderly woman with COVID-19 who developed a C. blankii bloodstream infection from a femoral central venous catheter. Asperg...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878287/ https://www.ncbi.nlm.nih.gov/pubmed/35205920 http://dx.doi.org/10.3390/jof8020166 |
_version_ | 1784658625522827264 |
---|---|
author | Mirchin, Ryan Czeresnia, Jonathan M. Orner, Erika P. Chaturvedi, Sudha Murphy, Kerry Nosanchuk, Joshua D. |
author_facet | Mirchin, Ryan Czeresnia, Jonathan M. Orner, Erika P. Chaturvedi, Sudha Murphy, Kerry Nosanchuk, Joshua D. |
author_sort | Mirchin, Ryan |
collection | PubMed |
description | Candida blankii is a recently recognized human pathogen, with most cases of the infection being reported in the immunocompromised. We here describe the case of a critically ill elderly woman with COVID-19 who developed a C. blankii bloodstream infection from a femoral central venous catheter. Aspergillus niger was also isolated from her respiratory secretions. The patient was started on voriconazole for empiric coverage of both A. niger, and at that time, unidentified yeast was found in the blood. Fevers persisted, and the patient expired six days after the yeast was first isolated. Almost one month after her death, C. blankii was identified as the cause of fungemia by sequencing of the internal transcribed spacer (ITS) region of the ribosomal gene and BLAST searching against two databases (performed by a reference laboratory). The isolate demonstrated high minimum inhibitory concentrations (MICs) to azoles and low MICs to amphotericin B, similar to previously described isolates. Timely identification of C. blankii would have prompted different empiric antifungal choices and possibly changed the final outcome. Clinicians should be aware of the pathological potential of C. blankii, the challenges of correctly identifying the organism, and its susceptibility patterns to common antifungals. There is an urgent need to improve assays for C. blankii identification, which will aid in accurate and timely pathogen identification, and appropriate therapeutic management. |
format | Online Article Text |
id | pubmed-8878287 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88782872022-02-26 The Continuing Emergence of Candida blankii as a Pathogenic Fungus: A New Case of Fungemia in a Patient Infected with SARS-CoV-2 Mirchin, Ryan Czeresnia, Jonathan M. Orner, Erika P. Chaturvedi, Sudha Murphy, Kerry Nosanchuk, Joshua D. J Fungi (Basel) Case Report Candida blankii is a recently recognized human pathogen, with most cases of the infection being reported in the immunocompromised. We here describe the case of a critically ill elderly woman with COVID-19 who developed a C. blankii bloodstream infection from a femoral central venous catheter. Aspergillus niger was also isolated from her respiratory secretions. The patient was started on voriconazole for empiric coverage of both A. niger, and at that time, unidentified yeast was found in the blood. Fevers persisted, and the patient expired six days after the yeast was first isolated. Almost one month after her death, C. blankii was identified as the cause of fungemia by sequencing of the internal transcribed spacer (ITS) region of the ribosomal gene and BLAST searching against two databases (performed by a reference laboratory). The isolate demonstrated high minimum inhibitory concentrations (MICs) to azoles and low MICs to amphotericin B, similar to previously described isolates. Timely identification of C. blankii would have prompted different empiric antifungal choices and possibly changed the final outcome. Clinicians should be aware of the pathological potential of C. blankii, the challenges of correctly identifying the organism, and its susceptibility patterns to common antifungals. There is an urgent need to improve assays for C. blankii identification, which will aid in accurate and timely pathogen identification, and appropriate therapeutic management. MDPI 2022-02-09 /pmc/articles/PMC8878287/ /pubmed/35205920 http://dx.doi.org/10.3390/jof8020166 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Mirchin, Ryan Czeresnia, Jonathan M. Orner, Erika P. Chaturvedi, Sudha Murphy, Kerry Nosanchuk, Joshua D. The Continuing Emergence of Candida blankii as a Pathogenic Fungus: A New Case of Fungemia in a Patient Infected with SARS-CoV-2 |
title | The Continuing Emergence of Candida blankii as a Pathogenic Fungus: A New Case of Fungemia in a Patient Infected with SARS-CoV-2 |
title_full | The Continuing Emergence of Candida blankii as a Pathogenic Fungus: A New Case of Fungemia in a Patient Infected with SARS-CoV-2 |
title_fullStr | The Continuing Emergence of Candida blankii as a Pathogenic Fungus: A New Case of Fungemia in a Patient Infected with SARS-CoV-2 |
title_full_unstemmed | The Continuing Emergence of Candida blankii as a Pathogenic Fungus: A New Case of Fungemia in a Patient Infected with SARS-CoV-2 |
title_short | The Continuing Emergence of Candida blankii as a Pathogenic Fungus: A New Case of Fungemia in a Patient Infected with SARS-CoV-2 |
title_sort | continuing emergence of candida blankii as a pathogenic fungus: a new case of fungemia in a patient infected with sars-cov-2 |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878287/ https://www.ncbi.nlm.nih.gov/pubmed/35205920 http://dx.doi.org/10.3390/jof8020166 |
work_keys_str_mv | AT mirchinryan thecontinuingemergenceofcandidablankiiasapathogenicfungusanewcaseoffungemiainapatientinfectedwithsarscov2 AT czeresniajonathanm thecontinuingemergenceofcandidablankiiasapathogenicfungusanewcaseoffungemiainapatientinfectedwithsarscov2 AT ornererikap thecontinuingemergenceofcandidablankiiasapathogenicfungusanewcaseoffungemiainapatientinfectedwithsarscov2 AT chaturvedisudha thecontinuingemergenceofcandidablankiiasapathogenicfungusanewcaseoffungemiainapatientinfectedwithsarscov2 AT murphykerry thecontinuingemergenceofcandidablankiiasapathogenicfungusanewcaseoffungemiainapatientinfectedwithsarscov2 AT nosanchukjoshuad thecontinuingemergenceofcandidablankiiasapathogenicfungusanewcaseoffungemiainapatientinfectedwithsarscov2 AT mirchinryan continuingemergenceofcandidablankiiasapathogenicfungusanewcaseoffungemiainapatientinfectedwithsarscov2 AT czeresniajonathanm continuingemergenceofcandidablankiiasapathogenicfungusanewcaseoffungemiainapatientinfectedwithsarscov2 AT ornererikap continuingemergenceofcandidablankiiasapathogenicfungusanewcaseoffungemiainapatientinfectedwithsarscov2 AT chaturvedisudha continuingemergenceofcandidablankiiasapathogenicfungusanewcaseoffungemiainapatientinfectedwithsarscov2 AT murphykerry continuingemergenceofcandidablankiiasapathogenicfungusanewcaseoffungemiainapatientinfectedwithsarscov2 AT nosanchukjoshuad continuingemergenceofcandidablankiiasapathogenicfungusanewcaseoffungemiainapatientinfectedwithsarscov2 |